PLUS, a new “pay-as-you-use” system from Laundrylux, was introduced at Clean 2013 in New Orleans.
Billing system overhauled at Optimus EMR
Jun 19, 2013
Optimus EMR Inc. announced the launch of its new Optimus Billing and Financial System (OBFS) last week.
The OBFS is fully integrated with the company’s EMR clinical system, sharing one point of entry...
Aldersgate Healthcare selects new workforce management tool
Jun 07, 2016
Aldersgate Healthcare Inc. has chosen a series of SmartLinx Solutions LLC. products to fulfill its workforce management needs.
Last week to enter McKnight’s Tech Awards
Jul 26, 2017
Don’t miss your chance to enter your facility in the McKnight’s Technology Awards. The deadline is 11:59 p.m. on Friday, July 28.
New method for teaching nursing
Jan 05, 2016
Simulation Education Solutions for Nursing was recently launched by the National League for Nursing’s Center for Innovation in Simulation and Technology and Laerdal Medical to create effective simulation...
ACO white paper geared toward post-acute providers
Sep 23, 2014
A new white paper focuses on what kinds of services accountable care organizations should provide in the post-acute spectrum.
Genesis HealthCare offers NADONA membership to all DONs
May 12, 2015
Genesis HealthCare announced it will provide membership to the National Association of Directors of Nursing Administration in Long Term Care (NADONA/LTC) to all its directors of nursing in each of its...
Relias Learning acquires RediLearning
Oct 27, 2015
Relias Learning has completed the acquisition of fellow professional education company RediLearning. The deal will allow 400 new senior care courses to be merged into the Relias library.
FDA alerts providers to lack of sterility in NuVision Pharmacy products
May 21, 2013
The Food and Drug Administration expanded an alert about NuVision Pharmacy of Dallas, TX, on Saturday. It said investigators found poor sterile production practices that raised concern about a lack of...
FDA panel approves first biosimilar drug
Mar 10, 2015
The Food and Drug Administration approved its first biosimilar product last week, opening the door for more costly drug alternatives.